Kindly MD (KDLY) Competitors $0.97 +0.06 (+6.92%) (As of 09:39 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends KDLY vs. MRAI, CCM, OPGN, PMD, TOI, BRTX, OTRK, ATIP, MGRX, and ATPCShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Marpai (MRAI), Concord Medical Services (CCM), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. Kindly MD vs. Marpai Concord Medical Services OpGen Psychemedics Oncology Institute BioRestorative Therapies Ontrak ATI Physical Therapy Mangoceuticals Agape ATP Kindly MD (NASDAQ:KDLY) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment. Is KDLY or MRAI more profitable? Kindly MD has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A Marpai -85.70%N/A -100.23% Does the media favor KDLY or MRAI? In the previous week, Marpai had 1 more articles in the media than Kindly MD. MarketBeat recorded 3 mentions for Marpai and 2 mentions for Kindly MD. Marpai's average media sentiment score of 0.30 beat Kindly MD's score of -0.14 indicating that Marpai is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kindly MD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Marpai 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, KDLY or MRAI? Kindly MD has higher earnings, but lower revenue than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MDN/AN/AN/AN/AN/AMarpai$37.15M0.61-$28.75M-$2.64-0.62 Do institutionals & insiders have more ownership in KDLY or MRAI? 49.8% of Marpai shares are held by institutional investors. 50.5% of Kindly MD shares are held by company insiders. Comparatively, 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer KDLY or MRAI? Marpai has a consensus target price of $6.00, indicating a potential upside of 265.85%. Given Marpai's stronger consensus rating and higher possible upside, analysts plainly believe Marpai is more favorable than Kindly MD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kindly MD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer KDLY or MRAI? Marpai received 2 more outperform votes than Kindly MD when rated by MarketBeat users. CompanyUnderperformOutperformKindly MDN/AN/AMarpaiOutperform Votes266.67% Underperform Votes133.33% SummaryMarpai beats Kindly MD on 9 of the 11 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLY vs. The Competition Export to ExcelMetricKindly MDHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.82M$652.95M$5.07B$8.90BDividend YieldN/A1.94%4.99%4.07%P/E RatioN/A22.3987.8613.46Price / SalesN/A4.441,228.8287.66Price / CashN/A25.4439.5136.27Price / Book1.682.796.946.30Net IncomeN/A-$10.72M$119.12M$225.93M7 Day Performance5.63%-1.16%-1.84%-1.32%1 Month Performance-27.39%-2.51%-3.65%0.60%1 Year PerformanceN/A387.32%31.64%26.23% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYKindly MD0.1582 of 5 stars$0.97+6.9%N/AN/A$5.82MN/A0.00N/AGap UpMRAIMarpai2.0113 of 5 stars$1.64+13.1%$6.00+265.9%+80.2%$22.53M$37.15M-0.62150CCMConcord Medical Services0.3453 of 5 stars$4.35-3.3%N/A-58.6%$18.88M$75.69M0.00970Gap UpOPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.64M$3.42M0.00100News CoveragePMDPsychemedics0.5329 of 5 stars$2.33-0.4%N/A+11.0%$13.72M$22.10M-4.57140TOIOncology Institute2.3174 of 5 stars$0.13-0.9%$2.50+1,808.4%-94.1%$9.89M$324.24M0.00660Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.7191 of 5 stars$1.41+0.9%$18.00+1,174.9%-22.2%$9.77M$150,000.00-0.927Analyst RevisionNews CoverageGap UpOTRKOntrak2.7304 of 5 stars$1.81-1.1%$45.00+2,386.2%-79.4%$7.64M$12.74M0.00250Gap DownATIPATI Physical Therapy0.224 of 5 stars$1.62+1.9%N/A-78.2%$7.14M$699.02M0.005,600MGRXMangoceuticals0.508 of 5 stars$2.39-3.2%N/A-98.1%$5.95M$730,000.000.003Gap DownATPCAgape ATP0.013 of 5 stars$1.44+2.9%N/A-92.4%$5.75M$1.43M0.0040 Related Companies and Tools Related Companies Marpai Alternatives Concord Medical Services Alternatives OpGen Alternatives Psychemedics Alternatives Oncology Institute Alternatives BioRestorative Therapies Alternatives Ontrak Alternatives ATI Physical Therapy Alternatives Mangoceuticals Alternatives Agape ATP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KDLY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.